Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

CorMedix Inc.

NASDAQ: CRMD · Life Sciences · 8 alerts · CIK 1410098

Share price
$4.82Close, Nov 16
Market cap
$383M
Shares outstanding
79.54MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All CorMedix Inc. filings on SEC EDGAR ↗

6:11 AM ET 8-K
M&A Deal

CorMedix M&A Deal with Heron Therapeutics, Inc.

CorMedix Inc. announced a definitive agreement to acquire substantially all of the assets of Heron Therapeutics, Inc., including both commercial and pipeline assets. The acquisition is intended to provide scale and diversification to CorMedix's institutional care growth strategy and remains subject to Heron stockholder approval and regulatory clearance.

Counterparty
Heron Therapeutics, Inc.
5:16 PM ET 8-K
M&A Deal

CorMedix M&A Deal with Heron Therapeutics, Inc.

CorMedix Inc. has entered into a definitive asset purchase agreement to acquire substantially all of the assets of Heron Therapeutics. The transaction will be funded in part through a new term loan facility with Pharmakon and the issuance of CorMedix common stock as consideration. The deal is expected to be accretive to earnings and free cash flow while providing operating cost synergies.

Counterparty
Heron Therapeutics, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.